Medicure (MCUJF) Non-Current Assets (2009 - 2026)
Medicure (MCUJF) posted quarterly Non-Current Assets of $9.2 million for Q1 2026, down 4.97% year-over-year from $9.7 million in Q1 2025, and down 0.9% quarter-over-quarter from $9.3 million in Q4 2025.
Medicure (MCUJF) Non-Current Assets (2009 - 2026) Analysis & Trends
Medicure's Non-Current Assets history runs 18 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 4.97% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $38.7 million (up 299.68% YoY), while the FY2025 annual figure was $9.3 million, down 7.24% from the prior year.
- Non-Current Assets for Q1 2026 stood at $9.2 million, down from $9.3 million in the prior quarter.
- The five-year high for Non-Current Assets was $12.1 million in Q3 2022, with the low at $9.0 million in Q2 2024.
- The 5-year median for Non-Current Assets is $9.9 million (2023), against an average of $10.2 million.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets decreased 16.25% in 2023, then advanced 14.36% in 2025.
- Medicure's Non-Current Assets stood at $11.0 million in 2022, then decreased by 14.5% to $9.4 million in 2023, then rose by 3.76% to $9.8 million in 2024, then slipped by 5.18% to $9.3 million in 2025, then declined by 0.9% to $9.2 million in 2026.
- Business Quant data shows MCUJF's Non-Current Assets at $9.2 million in Q1 2026, $9.3 million in Q4 2025, and $10.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.75 Bn | 40.09 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 32.76 Bn | 31.08 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.31 Bn | 19.65 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Medicure | 96.01 Mn | 94.89 Mn | 2.57 Mn | 9.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | 9.29 Mn |
| Sep 30, 2025 | 10.12 Mn |
| Jun 30, 2025 | 10.34 Mn |
| Mar 31, 2025 | 9.69 Mn |
| Dec 31, 2024 | 9.80 Mn |
| Sep 30, 2024 | 9.05 Mn |
| Jun 30, 2024 | 9.04 Mn |
| Mar 31, 2024 | 9.43 Mn |
| Dec 31, 2023 | 9.44 Mn |
| Sep 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 10.74 Mn |
| Dec 31, 2022 | 11.04 Mn |
| Sep 30, 2022 | 12.05 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 11.98 Mn |
| Dec 31, 2021 | 12.58 Mn |
| Sep 30, 2021 | 12.93 Mn |
| Jun 30, 2021 | 13.46 Mn |
| Mar 31, 2021 | 13.65 Mn |